LENZ Therapeutics (LENZ) Enterprise Value (2020 - 2026)
LENZ Therapeutics' (LENZ) quarterly Enterprise Value came in at -$258.4 million in Q1 2026, down 1015.84% year-on-year from $28.2 million in Q1 2025, and up 11.62% on a QoQ basis from -$292.3 million in Q4 2025.
LENZ Therapeutics (LENZ) Enterprise Value (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Enterprise Value data on file, last reported at -$258.4 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 1015.84% year-over-year to -$258.4 million in Q1 2026; TTM through Mar 2026 was -$258.4 million, a 1015.84% decrease from a year earlier, with the FY2025 full-year figure at -$292.3 million, down 1342.12% from the prior year.
- Enterprise Value for Q1 2026 stood at -$258.4 million, up from -$292.3 million in the prior quarter.
- Over the last five years, Enterprise Value for LENZ reached as high as -$20.3 million in Q4 2024 and fell as low as -$339.2 million in Q1 2022.
- Historically, Enterprise Value has averaged -$181.3 million across 5 years, with a median of -$202.2 million in 2023.
- On a YoY basis, Enterprise Value climbed as much as 88.45% in 2025 and fell as far as 1342.12% in 2025.
- Year by year, Enterprise Value stood at -$220.5 million in 2022, then jumped by 70.16% to -$65.8 million in 2023, then jumped by 69.19% to -$20.3 million in 2024, then sank by 1342.12% to -$292.3 million in 2025, then climbed by 11.62% to -$258.4 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$258.4 million in Q1 2026, -$292.3 million in Q4 2025, and -$202.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 | -258.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -258.39 Mn |
| Dec 31, 2025 | -292.35 Mn |
| Sep 30, 2025 | -202.17 Mn |
| Jun 30, 2025 | -37.71 Mn |
| Mar 31, 2025 | -23.16 Mn |
| Dec 31, 2024 | -20.27 Mn |
| Sep 30, 2024 | -41.15 Mn |
| Jun 30, 2024 | -84.14 Mn |
| Mar 31, 2024 | -200.46 Mn |
| Dec 31, 2023 | -65.79 Mn |
| Sep 30, 2023 | -233.99 Mn |
| Jun 30, 2023 | -246.67 Mn |
| Mar 31, 2023 | -202.25 Mn |
| Dec 31, 2022 | -220.50 Mn |
| Sep 30, 2022 | -291.69 Mn |
| Jun 30, 2022 | -322.29 Mn |
| Mar 31, 2022 | -339.18 Mn |
| Dec 31, 2021 | -376.98 Mn |
| Sep 30, 2021 | -394.95 Mn |
| Jun 30, 2021 | -382.11 Mn |